Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Morgan Stanley lifts Nutanix shares target, cites VMware deal as growth catalyst

EditorEmilio Ghigini
Published 27/03/2024, 13:02
Updated 27/03/2024, 13:02

On Wednesday, Morgan Stanley (NYSE:MS) maintained its Equalweight rating on shares of Nutanix (NASDAQ:NTNX), while increasing the price target to $63 from the previous $58. The firm's analysis indicates that Nutanix could see a revenue growth boost of 2-5% in the coming years, attributed to the potential increased traction for the company following Broadcom (NASDAQ:AVGO)'s acquisition of VMware (NYSE:VMW).

The assessment by Morgan Stanley reflects the feedback from resellers, who have observed a shift in market dynamics that could favor Nutanix. This shift is expected to potentially drive more business to Nutanix, as customers evaluate their options in light of the changes within the industry.

Morgan Stanley's stance remains cautious, as they anticipate a pullback that could affect the revenue opportunity for Nutanix. The firm advises keeping an eye on these key indicators that could impact the company's financial performance and growth trajectory in the near future.

InvestingPro Insights

InvestingPro data highlights Nutanix's (NASDAQ:NTNX) substantial market cap of $15.57 billion, which underlines the company's significant presence in the industry. With a robust revenue growth of 18.12% over the last twelve months as of Q2 2024, Nutanix demonstrates a capacity for expansion, which may align with Morgan Stanley's revenue growth boost projection. The company's impressive gross profit margin of 83.85% in the same period underscores its efficiency in maintaining profitability on its products and services.

Two InvestingPro Tips that are particularly relevant to Morgan Stanley's analysis include the expectation of net income growth this year and the fact that 11 analysts have revised their earnings upwards for the upcoming period. These insights could provide investors with additional confidence in Nutanix's financial outlook, complementing the positive sentiment from Morgan Stanley's increased price target.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro offers a comprehensive list of additional tips, with 12 more insights available that can further inform investment decisions. For those interested in a deeper analysis, using the coupon code PRONEWS24 will secure an additional 10% off a yearly or biyearly Pro and Pro+ subscription, granting access to these valuable insights.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.